Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal

Nigro, 1974, Combined therapy for cancer of the anal canal: A preliminary report, Dis Colon Rectum, 17, 354, 10.1007/BF02586980 1996, Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research, Lancet, 348, 1049, 10.1016/S0140-6736(96)03409-5 Bartelink, 1997, J Clin Oncol, 15, 2040, 10.1200/JCO.1997.15.5.2040 Flam, 1996, Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study, J Clin Oncol, 14, 2527, 10.1200/JCO.1996.14.9.2527 Kachnic, 2011, RTOG 0529: A phase II study of dose-painted IMRT (DP-IMRT), 5-fluorouracil, and mitomycin-C for the reduction of acute morbidity in anal cancer, J Clin Oncol, 29, 368, 10.1200/jco.2011.29.4_suppl.368 Lyman, 1985, Complication probability as assessed from dose-volume histograms, Radiat Res Suppl, 8, S13, 10.2307/3583506 Kutcher, 1989, Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method, Int J Radiat Oncol Biol Phys, 16, 1623, 10.1016/0360-3016(89)90972-3 Kutcher, 1991, Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations, Int J Radiat Oncol Biol Phys, 21, 137, 10.1016/0360-3016(91)90173-2 Mohan, 1992, Clinically relevant optimization of 3-D conformal treatments, Med Phys, 19, 933, 10.1118/1.596781 Niemierko, 1997, Reporting and analyzing dose distributions: A concept of equivalent uniform dose, Med Phys, 24, 103, 10.1118/1.598063 Emami, 1991, Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys, 21, 109, 10.1016/0360-3016(91)90171-Y Luxton, 2008, A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD), Phys Med Biol, 53, 23, 10.1088/0031-9155/53/1/002 Mell, 2008, Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy, Int J Radiat Oncol Biol Phys, 70, 1431, 10.1016/j.ijrobp.2007.08.074 Albuquerque, 2011, Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT, Int J Radiat Oncol Biol Phys, 79, 1043, 10.1016/j.ijrobp.2009.12.025 Mell, 2006, Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy, Int J Radiat Oncol Biol Phys, 66, 1356, 10.1016/j.ijrobp.2006.03.018 Rose, 2011, Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy, Int J Radiat Oncol Biol Phys, 79, 800, 10.1016/j.ijrobp.2009.11.010 Bazan, 2011, Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal, Cancer, 117, 3342, 10.1002/cncr.25901 Trotti, 2003, CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6 Daly, 2012, Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, 82, 2025, 10.1016/j.ijrobp.2011.03.004